How many insider disclosures are linked to Hamlet Biopharma AB (publ)?

Available records link 1 public disclosure to Hamlet Biopharma AB (publ), sourced from FIN-FSA.

Who is the top reporting insider at Hamlet Biopharma AB (publ)?

The top reporting insider at Hamlet Biopharma AB (publ) is Henrik Sundin, based on the count of public filings.

What declared insider buy and sell totals are available for Hamlet Biopharma AB (publ)?

Across the available history, declared buys total 0 and disposals 0.

← Companies ★ Sign in to follow

HB

Hamlet Biopharma AB (publ) Stock: price and management transactions · Finland · FIN-FSA

Source idFI:hamlet-biopharma-ab-publ·FIN-FSA

FIN-FSA

Follow the Hamlet Biopharma AB (publ) share price and the full insider trade history of the company, a listed equity based in Finland. Shares trade on the FI market, under the oversight of FIN-FSA. The latest transaction was disclosed on 3 August 2026 (Sale). Among the most active insiders: Henrik Sundin. The full history is openly available.

1

Insider Decl.

n/a

Thresholds

n/a

Buy Volume

n/a

1 ops.

Sell Volume

Sigma AI Analysis

Fundamental view, insider signal, bull and bear case, synthesis.

AI analysis generation is paused.

Last declaration on 3 August 2026

Declarations1 total

●

Henrik Sundin

StyrelseledamotExecutives30 Jul 2026

0FI-SE ↗

237,120 shares0TeckningsoptionFI:csv-c3f494f2faae37f416e1

1 of 1 declaration

InsidersTradesSigma

← Companies ★ Sign in to follow

HB

Hamlet Biopharma AB (publ) Stock: price and management transactions · Finland · FIN-FSA

Source idFI:hamlet-biopharma-ab-publ·FIN-FSA

FIN-FSA

Follow the Hamlet Biopharma AB (publ) share price and the full insider trade history of the company, a listed equity based in Finland. Shares trade on the FI market, under the oversight of FIN-FSA. The latest transaction was disclosed on 3 August 2026 (Sale). Among the most active insiders: Henrik Sundin. The full history is openly available.

1

Insider Decl.

n/a

Thresholds

n/a

Buy Volume

n/a

1 ops.

Sell Volume

Sigma AI Analysis

Fundamental view, insider signal, bull and bear case, synthesis.

AI analysis generation is paused.

Last declaration on 3 August 2026

Declarations1 total

●

Henrik Sundin

StyrelseledamotExecutives30 Jul 2026

0FI-SE ↗

237,120 shares0TeckningsoptionFI:csv-c3f494f2faae37f416e1

1 of 1 declaration

Hamlet Biopharma AB (publ) Stock: price and management transactions · Finland · FIN-FSA

Related companies and executives

Hamlet Biopharma AB (publ) Stock: price and management transactions · Finland · FIN-FSA

Related companies and executives